Phase I Safety Profile: While topical and low-dose injectable formulations demonstrate high tolerance and minimal systemic toxicity, there is no formal Phase I safety data for chronic 85 mg/day intranasal delivery in humans
Its short half-life, however, required it to be injected several times a day, which limited its appeal as a drug, and the company ran out of funding
At the same time, hepcidin is also regulated by inflammation, and the expression of serum hepcidin in patients with cerebral hemorrhage is increased (Ganz and Nemeth, 2012)
Conclusion FreSHtracer selectively isolates highly functional MSCs that have enhanced in vitro chondrogenesis and in vivo hyaline cartilage regeneration, which can ultimately overcome the current limitations of MSC therapy
How It May Work: Vitamin D influences brain development and neurotransmitter regulation
Talk to a doctor to find out whats best for you